We’re in San Sebastián 🇪🇸 with one of the top VCs in Europe, Christina Takke from V-Bio Ventures.
We talk about her path to get to the top and the benefits of gender diversity for both investing and European biotech as a whole. We also talk about her investment in Argenx when it was only three employees and the venture creation had dropped since 2022.
💎 ABOUT THE SPEAKER
Christina co-founded V-Bio Ventures in 2015 and is now the Managing Partner. Before this, she was a leader in the European Venture Capital world with 15 years of experience. She has been a partner at Forbion Capital Partners where she led many successful investments in biopharma and pharma companies.
🔗 LINKS MENTIONED
- Lean years for company creation in Europe? - BioVox, Sep 2023 - https://biovox.eu/lean-years-for-company-creation-in-europe/
📜 TRANSCRIPT
Read the full transcript here: https://flot.bio/episode/christina-takke-v-bio-ventures/
💸 DONATE
We welcome donations from individuals and businesses to support our more content creation: https://www.paypal.me/PhilipHemme⭐️
SPONSORSHIP
Ready to amplify your brand to influential leaders in biotech and biopharma? Contact [email protected] and unlock sponsorship opportunities in our podcasts!
🫶 FOLLOW US
- Newsletter: http://eepurl.com/h_fnmH
- LinkedIn: https://www.linkedin.com/company/flot-bio/
- X (Twitter): https://x.com/FlotBio
🙏 LIKE/FOLLOW/REVIEW
Did you enjoy the episode? Please hit the like and subscribe button. Also, please let me know your thoughts in the comments below.
🎙️ ABOUT FLOT.BIO
Flot.bio is a show to watch the best Europeans in biotech to help you grow. Hosted by Philip Hemme. 15k monthly views. Free.
⏰ TIMESTAMPS
[00:00:00] Intro
[00:02:03] Top VC woman in biotech
[00:08:36] European background
[00:13:49] Investing in Argenx at the start
[00:20:26] V-Bio story
[00:25:09] Tech transfer
[00:35:44] Company creation drop
[00:42:39] Thanks for listening